Selection of immunoglobulin diversity gene reading frames in B cell lymphoproliferative disorders

Leukemia

Volumn 13, Issue 4, 1999, Pages 601-604

  Stamatopoulos, K ^a   Kosmas, C ^a   Stavroyianni, N ^a   Belessi, C ^a   Papadaki, T ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

D gene; Immunoglobulin genes; Reading frame

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; DNA SEQUENCE; FOLLICULAR LYMPHOMA; GENE FREQUENCY; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0032912239     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401396     Document Type: Article

References (31)

1. Schatz DG, Oettinger MA, Schlissel MS. V(D)J recombination: molecular biology and regulation. Annu Rev Immunol 1992; 10: 359-383.
2. Martin TE, Crouzier R, Weber J-C, Kipps TJ, Pasquali J-L. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J Immunol 1994; 152: 5988-5996.
3. Padlan EA. Anatomy of the antibody molecule. Mol Immunol 1994; 31: 169-217.
4. Padlan EA. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 1990; 7: 112-124.
5. Raaphorst FM, Raman CS, Nail BT, Teale JM. Molecular mechanisms governing reading frame choice of immunoglobulin diversity genes. Immunol Today 1997; 18: 37-43.
6. - B cells. J Clin Invest 1997; 99: 2488-2501.
7. Steenbergen EJ, Verhagen OJHM, van Leeuwen EF, Behrendt H, Merle PA, Wester MR, von dem Borne AEGK, van der Schoot CE. B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Eur J Immunol 1994; 24: 900-908.
8. H1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997; 158: 235-246.
9. L regions expressed in IgG-bearing chronic lymphocytic leukemia: further evidence that CLL is a heterogeneous group of tumors. Blood 1993; 82: 1626-1631.
10. + B cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood 1993; 82: 3103-3112.
11. Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ. Common clonal origin of chronic lymphocytic leukemia and high-grade lymphoma of Richter's syndrome. Blood 1993; 82: 3141-3147.
12. Stamatopoulos K, Kosmas C, Stavroylanni N, Loukopoulos D. Evidence for immunoglobulin heavy chain variable region gene replacement in a patient with B cell chronic lymphocytic leukemia. Leukemia 1996; 10: 1551-1556.
13. - B cell chronic lymphocytic leukemia. Blood 1995; 86: 3883-3890.
14. Stamatopoulos K, Kosmas C, Papadaki T, Pouliou E, Belessi C, Afendaki S, Anagnostou D, Loukopoulos D. Follicular lymphoma immunoglobulin κ light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br J Haematol 1997; 96: 132-146.
15. H and at later stages in the rearrangement process of the immunoglobulin heavy chain gene locus. Br J Haematol 1997; 99: 866-872.
16. Billadeau D, Ahman G, Grelpp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 1993; 178: 1023-1031.
17. Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thlelemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutation. Blood 1992; 80: 2326-2335.
18. Bakkus MHC, Van Riet I, Van Camp B, Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol 1994; 87: 68-74.
19. H sequences reveal a complementary imprint of antigen selection in tumor cells. Blood 1997; 89: 219-226.
20. H4 Ig gene family by diffuse large cell lymphoma. Blood 1995; 86: 3072-3082.
21. Przybylski GK, Goldman J, Ng VL, McGrath MS, Herndler BG, Schenkein DP, Monroe JG, Silberstein LE. Evidence for early B cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 1996; 88: 4620-4629.
22. H genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 1995; 85: 2176-2181.
23. L gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 1996; 88: 3562-3568.
24. Ichihara Y, Matsuoka H, Kurosawa Y. Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 1988; 7: 4141-4150.
25. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 1991; 173: 395-407.
26. Shipp MA, Mauch PM, Harris NL. Non-Hodgkin's lymphomas. In: DeVita VT, Hellman S, Rosenberg SA (eds). Principles and Practice of Oncology, 5th edn. Lippincott-Raven: Philadelphia, 1997, pp 2165-2220.
27. Schroeder HW, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994; 15: 288-294.
28. Kosmas C, Stamatopoulos K, Papadaki T, Belessi C, Yataganas X, Anagnostou D, Loukopoulos D. Somatic hypermutation of immunoglobulin genes: focus on follicular lymphoma and multiple myeloma. Immunol Rev 1998; 162: 281-292.
29. Millil M, Schiff C, Fougereau M, Tonnelle C. The VDJ repertoire expressed in human pre-B cells reflects the selection of bona fide heavy chains. Eur J Immunol 1996; 26: 63-69.
30. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfklaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
31. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, Küppers R. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998; 162: 261-280.